THESEUS PHARMACEUTICALS, INC. Shareholders' Equity
THESEUS PHARMACEUTICALS, INC. had Shareholders' Equity of $224.52 million as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-11-17
- 2023-09-30: Stockholders' Equity Attributable to Parent $224.52M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $234.08M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $245.49M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $207.62M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-09-30 | $224.52M 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $234.08M 10-Q · filed 2023-11-17 | |
| 2023-03-31 | $245.49M 10-Q · filed 2023-11-17 | |
| 2022-12-31 | $207.62M 10-Q · filed 2023-11-17 | |
| 2022-09-30 | $218.59M 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $229.00M 10-Q · filed 2023-11-17 | |
| 2022-03-31 | $237.85M 10-Q · filed 2023-11-17 | |
| 2021-12-31 | $246.43M 10-Q · filed 2023-11-17 | |
| 2021-09-30 | -$50.15M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$44.07M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | -$38.20M 10-Q · filed 2022-11-03 | -$38.70M 10-Q · filed 2021-11-15 |
| 2020-12-31 | -$34.27M 10-K · filed 2023-03-09 | |
| 2020-09-30 | -$18.25M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$16.85M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$11.64M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$9.41M 10-K · filed 2022-03-10 |